Risk Factors for Failure of Lower-Extremity Revascularization Procedures: Are They Different for Bypass and Percutaneous Procedures?
- 1 September 2008
- journal article
- review article
- Published by Elsevier in Seminars in Vascular Surgery
- Vol. 21 (3) , 143-153
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- CryoPlasty Therapy of the Superficial Femoral and Popliteal Arteries: A Single Center ExperienceVascular and Endovascular Surgery, 2007
- Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventionsJournal of Vascular Surgery, 2007
- Shifting Paradigms in the Treatment of Lower Extremity Vascular DiseaseAnnals of Surgery, 2007
- Genomewide Association Analysis of Coronary Artery DiseaseNew England Journal of Medicine, 2007
- Percutaneous treatment of peripheral vascular disease: The role of diabetes and inflammationJournal of Vascular Surgery, 2007
- Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation, invasion, and mitogen-activated protein kinase activation in vitro compared with paired internal mammary artery cellsJournal of Vascular Surgery, 2007
- Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgeryJournal of Vascular Surgery, 2007
- Resource utilization in the treatment of critical limb ischemia: the effect of tissue loss, comorbidities, and graft-related eventsJournal of Vascular Surgery, 2006
- Hemodynamic outcome of endovascular therapy for transatlantic intersociety consensus type B femoropopliteal arterial occlusive lesionsJournal of Vascular Surgery, 2004
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991